<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25070">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01922414</url>
  </required_header>
  <id_info>
    <org_study_id>Staghorn Laser</org_study_id>
    <secondary_id>Staghorn Laser vs US</secondary_id>
    <nct_id>NCT01922414</nct_id>
  </id_info>
  <brief_title>Laser Versus Ultrasound Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones</brief_title>
  <official_title>Laser Versus Ultrasound Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to compare the results of Laser and ultrasound lithotripsy in
      disintegration of staghorn stones during percutaneous nephrolithotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with complete staghorn stones who are eligible to percutaneous nephrolithotomy
      (PNL) will be randomized between two groups.

      Group 1: will undergo Laser lithotripsy during PNL Group 2: will undergo ultrasound
      lithotripsy during PNL
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Assessment of the impact of lithotripsy device on operative time</measure>
    <time_frame>Time needed to complete the procedure for each patient, an expected average of 3 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the impact of lithotripsy device on intraoperative complications</measure>
    <time_frame>participants will be assessed for the duration of surgery, an expected average of 3 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications of the procedure</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 5 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Complications will be graded according to modified Clavien grading system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stone free rate</measure>
    <time_frame>up to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The stone free rate will be evaluated with non-contrast CT 3 months after PNL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Staghorn Stones</condition>
  <arm_group>
    <arm_group_label>Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo Laser lithotripsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo ultrasound lithotripsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser</intervention_name>
    <description>Patients will undergo laser lithotripsy durin PNL</description>
    <arm_group_label>Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Patients will undergo ultrasound lithotripsy during PNL</description>
    <arm_group_label>Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Complete staghorn stones (filling the renal pelvis and branching to 3 major calyces

          2. Age: 18-70 years

        Exclusion Criteria:

          1. Congenital renal anomalies such as horse shoe kidney.

          2. Contraindications to PNL such as bleeding tendency and uncontrolled hypertension.

          3. Associated pathological features requiring open intervention such as UPJO

          4. Partial staghorn stones (filling the renal pelvis and branching to 2 major calyces)

          5. Giant staghorn stone (very large staghorn stone that branch and re-branch in hugely
             dilated calyceal system)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed R. EL-Nahas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed R. EL-Nahas, MD</last_name>
    <phone>0020502262222</phone>
    <phone_ext>1699</phone_ext>
    <email>ar_el_nahas@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed M Elshal</last_name>
    <phone>0020502262222</phone>
    <email>elshalam@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>Dakhlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed R. EL-Nahas, MD</last_name>
      <phone>0020502262222</phone>
      <phone_ext>1699</phone_ext>
      <email>ar_el_nahas@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed M Elshal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 20, 2013</lastchanged_date>
  <firstreceived_date>August 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ahmed R. EL-Nahas</investigator_full_name>
    <investigator_title>Assistant Professor of Urology</investigator_title>
  </responsible_party>
  <keyword>Staghorn stones</keyword>
  <keyword>Percutaneous nephrolithotomy</keyword>
  <keyword>Laser</keyword>
  <keyword>Randomized trial</keyword>
  <keyword>Lithotripsy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
